Method for determining genotoxic impurities of sucrose octasulfate potassium salt

Through the HPLC method combined with specific chromatographic conditions, the problem of detection of genotoxic impurities in potassium salt of sucrose octasulfate was solved, and effective separation and analysis of pyridine N oxide and 2-methylpyridine N oxide was achieved, and product quality was improved The specificity and resolution of control meet the detection requirements of the pharmacopoeia standards.

CN119064482APending Publication Date: 2024-12-03JIANGSU SKYRUN PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310644448.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-02
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The prior art lacks effective detection methods to isolate and analyze the possible genotoxic impurities pyridine N oxide and 2-methylpyridine N oxide in the potassium salt of sucrose octasulfate, making it difficult to control product quality.

Method used

Using HPLC method, pyridine N oxidation is achieved through specific chromatographic conditions such as octadecylsilane-bonded silica gel filler, 0.1% triethylamine aqueous mobile phase and acetonitrile mobile phase, combined with appropriate pH adjustment and temperature control. Effective separation and accurate analysis of substances and 2-methylpyridine N oxides.

Benefits of technology

The traceability and accurate detection of genotoxic impurities in the potassium salt of sucrose octasulfate was achieved, the specificity and separation of product quality control were improved, and the detection requirements of pharmacopoeia standards were met.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119064482A_ABST
    Figure CN119064482A_ABST
Patent Text Reader

Abstract

The invention provides a method for determining genotoxic impurities of sucrose octasulfate potassium salt, and particularly relates to the field of medicines. Octadecylsilane chemically bonded silica is used as a filler, a 0.1% triethylamine aqueous solution is used as a mobile phase A, and acetonitrile is used as a mobile phase B; carrying out isocratic elution on the mobile phase A and the mobile phase B in a ratio of 85: 15; the column temperature is 43-47 DEG C, the flow velocity is 1.1-1.3 ml / min, the wavelength is 252-256 nm, the sample size is 15-25 [mu] l, and the operation time is 8-12 min; taking a proper amount of pyridine N oxide and 2-methylpyridine N oxide to prepare a reference substance solution containing 0.0004 mg per 1 ml, taking 20 [mu] 1 of the reference substance solution, injecting the reference substance solution into a liquid chromatograph, and recording a chromatogram; the method comprises the following steps: taking 200mg of a to-be-detected sample, precisely weighing, placing in a 10ml measuring flask, adding a diluent for dissolving and diluting to a scale, and uniformly shaking to obtain a test solution; precisely measuring 20 microliters of the test solution and 20 microliters of the reference solution, injecting the test solution and the reference solution into a liquid chromatograph, and recording chromatograms; the method provided by the invention can effectively separate and accurately analyze each impurity, has strong specificity and good separation degree, and can effectively control the product quality.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of medicine, and in particular relates to a method for determining genotoxic impurities of sucrose octasulfate potassium salt. Background Art

[0002] Sucrose octasulfate potassium salt excipients are not included in the pharmacopoeias of various countries. Sucrose octasulfate potassium salt may contain genotoxic impurities such as byproducts pyridine N-oxide and 2-methylpyridine N-oxide during the synthesis process. Therefore, an HPLC method that can detect trace amounts of pyridine N-oxide and 2-methylpyridine N-oxide in sucrose octasulfate potassium salt excipients was developed. Pyridine N-oxide and 2-methylpyridine N-oxide are genotoxic impurities with warning structures. According to the Threshold of Toxicological Concern (TTC) of genotoxic impurities: 1.5 micrograms / day, according to the usage and dosage of sucrose octasulfate potassium salt in irinotecan liposomes, the maximum daily dose of sucrose octasulfate potassium salt is 60.06 mg, that is, the limit of pyridine N-oxide and 2-methylpyridine N-oxide is 24 ppm. There is no detection method included in the pharmacopoeias of various countries for the auxiliary material sucrose octasulfate potassium salt, and no public literature has mentioned the HPLC detection method for ultra-trace pyridine N-oxide and 2-methylpyridine N-oxide. Summary of the invention

[0003] The invention aims to provide a method for determining genotoxic impurities of sucrose octasulfate potassium salt, which can effectively separate and accurately analyze various impurities, has strong specificity and good separation degree, and can effectively control product quality.

[0004] The present invention provides the following technical solutions:

[0005] A method for determining genotoxic impurities of sucrose octasulfate potassium salt is as follows:

[0006] The chromatographic conditions were as follows:

[0007] Octadecylsilane bonded silica gel was used as filler, 0.1% triethylamine aqueous solution was used as mobile phase A, the pH of mobile phase A was adjusted to 2.5-3.5, and acetonitrile was used as mobile phase B;

[0008] Mobile phase A: mobile phase B = 85:15 isocratic elution; column temperature 43-47°C, flow rate 1.1-1.3 ml / min, wavelength 252-256 nm, injection volume 15-25 μl, running time 8-12 min, use mobile phase as diluent;

[0009] The chromatography test process is as follows:

[0010] Take appropriate amounts of pyridine N-oxide and 2-methylpyridine N-oxide to prepare a reference solution containing 0.0004 mg per 1 ml, inject 20 μl of the reference solution into a liquid chromatograph, and record the chromatogram;

[0011] Take 200 mg of the sample to be tested, accurately weigh it, put it in a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and use it as the test solution; accurately measure 20 μl of the test solution and the reference solution respectively, inject them into the liquid chromatograph, and record the chromatogram.

[0012] Preferably, the chromatographic column is C18 5 μm, 4.6×250 mm.

[0013] Preferably, mobile phase A is adjusted to pH 3.00 with phosphoric acid.

[0014] Preferably, the column temperature is 45° C., the flow rate is 1.2 ml / min, the wavelength is 254 nm, the injection volume is 20 μl, and the running time is 10 min.

[0015] Preferably, the theoretical plate number of pyridine N-oxide and 2-methylpyridine N-oxide in the reference solution is greater than 2000.

[0016] Preferably, the peak areas of pyridine N-oxide and 2-methylpyridine N-oxide in the test sample are smaller than the peak areas of the main peaks in the control solution.

[0017] Beneficial effects of the present invention:

[0018] (1) The present invention is the first to trace the source of genotoxic impurities in sucrose octasulfate potassium salt and identify two genotoxic related substances, providing a reliable impurity spectrum reference for the study of genotoxic related substances in sucrose octasulfate potassium salt and its preparations, which has a great positive progress effect and practical application value.

[0019] (2) The method for detecting genotoxic substances related to sucrose octasulfate potassium salt provided by the present invention can effectively separate and accurately analyze various impurities, has strong specificity and good separation degree, and can effectively control product quality. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:

[0021] Figure 1 This is a typical spectrum of blank solution for genotoxic impurity detection of sucrose octasulfate potassium salt;

[0022] Figure 2 This is a typical spectrum of the reference solution for the detection of genotoxic impurities of sucrose octasulfate potassium salt;

[0023] Figure 3 This is a typical spectrum of the spiked test solution for the detection of genotoxic impurities in sucrose octasulfate potassium salt;

[0024] Figure 4 This is a typical spectrum of blank solution for detecting genotoxic impurities of sucrose octasulfate potassium salt in Example 2;

[0025] Figure 5 Typical spectrum of the reference solution for the detection of genotoxic impurities of sucrose octasulfate potassium salt in Example 2;

[0026] Figure 6 Typical spectrum of blank solution for genotoxic impurity detection of sucrose octasulfate potassium salt in Example 3;

[0027] Figure 7 This is a typical spectrum of the reference solution for the detection of genotoxic impurities in Example 3 of sucrose octasulfate potassium salt. DETAILED DESCRIPTION

[0028] Embodiment 1:

[0029] The chromatographic conditions were as follows:

[0030] Octadecylsilane bonded silica gel was used as filler, the chromatographic column was CAPCELL PAK C18 5μm, 4.6×250mm, 0.1% triethylamine aqueous solution was used as mobile phase A, the pH of mobile phase A was adjusted to 2.5-3.5, and acetonitrile was used as mobile phase B;

[0031] Mobile phase A:mobile phase B=85:15 isocratic elution; column temperature 43°C, flow rate 1.1 ml / min, wavelength 252 nm, injection volume 15 μl, running time 8 min, using mobile phase as diluent;

[0032] The chromatography test process is as follows:

[0033] Take appropriate amounts of pyridine N-oxide and 2-methylpyridine N-oxide to prepare a reference solution containing 0.0004 mg per 1 ml. Take 20 μl of the reference solution and inject it into the liquid chromatograph to record the chromatogram.

[0034] Take 200 mg of the sample to be tested, weigh it accurately, put it in a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and use it as the test solution; accurately measure 20 μl of the test solution and reference solution, inject them into the liquid chromatograph, and record the chromatogram. For details of the chromatogram, see Figures 1 to 3 The horizontal axis unit of the chromatogram is min, and the vertical axis unit is mAU.

[0035]

[0036]

[0037] Embodiment 2:

[0038] The chromatographic conditions were as follows:

[0039] Octadecylsilane bonded silica gel was used as filler, the chromatographic column was CAPCELL PAK C18 5μm, 4.6×250mm, 0.1% triethylamine aqueous solution was used as mobile phase A, the pH of mobile phase A was adjusted to 3 with phosphoric acid, and acetonitrile was used as mobile phase B;

[0040] Mobile phase A:mobile phase B=85:15 isocratic elution; column temperature 45°C, flow rate 1.2ml / min, wavelength 254nm, injection volume 20μl, running time 10min, using mobile phase as diluent;

[0041] The chromatography test process is as follows:

[0042] Take appropriate amounts of pyridine N-oxide and 2-methylpyridine N-oxide to prepare a reference solution containing 0.0004 mg per 1 ml. Take 20 μl of the reference solution and inject it into the liquid chromatograph to record the chromatogram.

[0043] Take 200 mg of the sample to be tested, weigh it accurately, put it in a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and use it as the test solution; accurately measure 20 μl of the test solution and reference solution, inject them into the liquid chromatograph, and record the chromatogram. For details of the chromatogram, see Figure 4-Figure 5 The horizontal axis unit of the chromatogram is min, and the vertical axis unit is mAU.

[0044] The test results are as follows:

[0045]

[0046]

[0047] Embodiment 3:

[0048] The chromatographic conditions were as follows:

[0049] Octadecylsilane bonded silica gel was used as filler, the chromatographic column was CAPCELL PAK C18 5μm, 4.6×250mm, 0.1% triethylamine aqueous solution was used as mobile phase A, the pH of mobile phase A was adjusted to 2.5-3.5, and acetonitrile was used as mobile phase B;

[0050] Mobile phase A:mobile phase B=85:15 isocratic elution; column temperature 47°C, flow rate 1.3ml / min, wavelength 256nm, injection volume 25μl, running time 12min, using mobile phase as diluent;

[0051] The chromatography test process is as follows:

[0052] Take appropriate amounts of pyridine N-oxide and 2-methylpyridine N-oxide to prepare a reference solution containing 0.0004 mg per 1 ml. Take 20 μl of the reference solution and inject it into the liquid chromatograph to record the chromatogram.

[0053] Take 200 mg of the sample to be tested, weigh it accurately, put it in a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and use it as the test solution; accurately measure 20 μl of the test solution and reference solution, inject them into the liquid chromatograph, and record the chromatogram. For details of the chromatogram, see Figure 6-Figure 7 The horizontal axis unit of the chromatogram is min, and the vertical axis unit is mAU.

[0054] The test results are as follows:

[0055]

[0056]

[0057] From Examples 1 to 3, it can be seen that after the optimization screening of mobile phase ratio, mobile phase pH, flow rate, column temperature, etc., the analytical method of the present invention is finally determined. At the same time, according to the definition and verification method of the General Rules 0512 (High Performance Liquid Chromatography) and General Rules 9101 (Guidelines for Validation of Drug Quality Standard Analytical Methods) of the 2020 edition of the Chinese Pharmacopoeia, specificity and system suitability, linearity and range, accuracy, precision, durability, etc. are verified. The results show that the method has strong specificity, good separation and accuracy, and can effectively control the quality of this product.

[0058] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for determining genotoxic impurities in sucrose octasulfate potassium salt, Features: The chromatographic conditions were as follows: Octadecylsilane bonded silica gel was used as filler, 0.1% triethylamine aqueous solution was used as mobile phase A, the pH of mobile phase A was adjusted to 2.5-3.5, and acetonitrile was used as mobile phase B; Mobile phase A: mobile phase B = 85:15 isocratic elution; column temperature 43-47°C, flow rate 1.1-1.3 ml / min, wavelength 252-256 nm, injection volume 15-25 μl, running time 8-12 min, use mobile phase as diluent; The chromatography test process is as follows: Take appropriate amounts of pyridine N-oxide and 2-methylpyridine N-oxide to prepare a reference solution containing 0.0004 mg per 1 ml, inject 20 μl of the reference solution into a liquid chromatograph, and record the chromatogram; Take 200 mg of the sample to be tested, weigh it accurately, put it in a 10 ml volumetric bottle, add diluent to dissolve and dilute to the scale, shake well, and use it as the test solution; Accurately measure 20 μl of the test solution and the reference solution and inject them into the liquid chromatograph to record the chromatogram.

2. A method for determining genotoxic impurities in sucrose octasulfate potassium salt according to claim 1, Features: The chromatographic column is C18 5μm, 4.6×250mm.

3. The method for determining genotoxic impurities of sucrose octasulfate potassium salt according to claim 1, It is characterized in that The pH of mobile phase A was adjusted to 3.00 with phosphoric acid.

4. The method for determining genotoxic impurities of sucrose octasulfate potassium salt according to claim 1, Features: The column temperature was 45°C, the flow rate was 1.2 ml / min, the wavelength was 254 nm, the injection volume was 20 μl, and the running time was 10 min.

5. The method for determining genotoxic impurities of sucrose octasulfate potassium salt according to claim 1, Features: The theoretical plate numbers of pyridine N-oxide and 2-methylpyridine N-oxide in the reference solution are greater than 2000.

6. A method for determining genotoxic impurities in sucrose octasulfate potassium salt according to claim 1, Features: The peak areas of pyridine N-oxide and 2-methylpyridine N-oxide in the tested samples are smaller than the peak areas of the main peaks in the control solution.